Can pharma advertisers and marketers finally get a little bit excited about Twitter/X again? With Musk’s intention to clean up after the acquisition, especially in content moderation, Twitter should have served as a safe and effective space for pharma advertisers. When speaking with any advertiser in pharma during this period, the most common fear centered around content moderation. That said, ads don’t make people want to use an app, but Thread will certainly serve a purpose for advertisers. Will Twitter/X recover enough trust that conservative and regulated industries might feel comfortable with the platform’s direction to engage again?

Source: CNN September 06, 2023 19:41 UTC